Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen MacMahon

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Stroke|April 27, 2012
Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trialHisatomi Arima, Craig Anderson, Teruo Omae, et al.
BMC Public Health|April 12, 2014
Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trialLijing L Yan, Weigang Fang, Elizabeth Delong, et al.
BMJ Open|November 21, 2012
The Treatment of cardiovascular Risk in Primary care using Electronic Decision supOrt (TORPEDO) study-intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcareDavid Peiris, Tim Usherwood, Katie Panaretto, et al.
Plos Medicine|August 29, 2012
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisJicheng Lv, Bruce Neal, Parya Ehteshami, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2014
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trialHisatomi Arima, Craig Anderson, Teruo Omae, et al.
Stroke|April 22, 2006
Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trialHisatomi Arima, Christophe Tzourio, Ken Butcher, et al.
Circulation|September 8, 2005
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging SubstudyCarole Dufouil, John Chalmers, Oguzhan Coskun, et al.
Diabetes, Obesity & Metabolism|March 30, 2021
Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trialJessica Gong, Katie Harris, Maree Hackett, et al.
Systematic Reviews|November 30, 2012
Study protocol: systematic review of the burden of heart failure in low- and middle-income countriesDerrick A Bennett, Thomas K Eliasz, Anna Forbes, et al.
Cerebral Circulation - Cognition and Behavior|January 6, 2025
Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trialKatie Harris, Jessica Gong, Stephen MacMahon, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Stroke|April 27, 2012
Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trialHisatomi Arima, Craig Anderson, Teruo Omae, et al.
BMC Public Health|April 12, 2014
Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trialLijing L Yan, Weigang Fang, Elizabeth Delong, et al.
BMJ Open|November 21, 2012
The Treatment of cardiovascular Risk in Primary care using Electronic Decision supOrt (TORPEDO) study-intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcareDavid Peiris, Tim Usherwood, Katie Panaretto, et al.
Plos Medicine|August 29, 2012
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisJicheng Lv, Bruce Neal, Parya Ehteshami, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2014
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trialHisatomi Arima, Craig Anderson, Teruo Omae, et al.
Stroke|April 22, 2006
Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trialHisatomi Arima, Christophe Tzourio, Ken Butcher, et al.
Circulation|September 8, 2005
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging SubstudyCarole Dufouil, John Chalmers, Oguzhan Coskun, et al.
Diabetes, Obesity & Metabolism|March 30, 2021
Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trialJessica Gong, Katie Harris, Maree Hackett, et al.
Systematic Reviews|November 30, 2012
Study protocol: systematic review of the burden of heart failure in low- and middle-income countriesDerrick A Bennett, Thomas K Eliasz, Anna Forbes, et al.
Cerebral Circulation - Cognition and Behavior|January 6, 2025
Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trialKatie Harris, Jessica Gong, Stephen MacMahon, et al.
Pageof 11